Can 4D bioprinting revolutionize drug development? Article Swipe
Izeia Lukin
,
Saioa Musquiz
,
Itsasne Erezuma
,
Taleb H. Al‐Tel
,
Nasim Golafshan
,
Alireza Dolatshahi‐Pirouz
,
Gorka Orive
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1080/17460441.2019.1636781
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1080/17460441.2019.1636781
\n Contains fulltext :\n 215393.pdf (Publisher’s version ) (Closed access)\n
Related Topics
Concepts
Metadata
- Type
- editorial
- Language
- en
- Landing Page
- https://doi.org/10.1080/17460441.2019.1636781
- https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1636781?needAccess=true
- OA Status
- bronze
- Cited By
- 35
- References
- 29
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2961547708
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2961547708Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1080/17460441.2019.1636781Digital Object Identifier
- Title
-
Can 4D bioprinting revolutionize drug development?Work title
- Type
-
editorialOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-07-08Full publication date if available
- Authors
-
Izeia Lukin, Saioa Musquiz, Itsasne Erezuma, Taleb H. Al‐Tel, Nasim Golafshan, Alireza Dolatshahi‐Pirouz, Gorka OriveList of authors in order
- Landing page
-
https://doi.org/10.1080/17460441.2019.1636781Publisher landing page
- PDF URL
-
https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1636781?needAccess=trueDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1636781?needAccess=trueDirect OA link when available
- Concepts
-
Biomedicine, 3D bioprinting, Drug development, Regeneration (biology), Drug, Nanotechnology, Medicine, Computer science, Bioinformatics, Biology, Pharmacology, Biomedical engineering, Tissue engineering, Materials science, Cell biologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
35Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 4, 2024: 7, 2023: 4, 2022: 10, 2021: 7Per-year citation counts (last 5 years)
- References (count)
-
29Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2961547708 |
|---|---|
| doi | https://doi.org/10.1080/17460441.2019.1636781 |
| ids.doi | https://doi.org/10.1080/17460441.2019.1636781 |
| ids.mag | 2961547708 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/31282226 |
| ids.openalex | https://openalex.org/W2961547708 |
| fwci | 2.15724334 |
| mesh[0].qualifier_ui | Q000379 |
| mesh[0].descriptor_ui | D062028 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | methods |
| mesh[0].descriptor_name | Bioprinting |
| mesh[1].qualifier_ui | Q000379 |
| mesh[1].descriptor_ui | D000076722 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | methods |
| mesh[1].descriptor_name | Drug Development |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D006801 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Humans |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D066330 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Printing, Three-Dimensional |
| mesh[4].qualifier_ui | Q000379 |
| mesh[4].descriptor_ui | D023822 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | methods |
| mesh[4].descriptor_name | Tissue Engineering |
| mesh[5].qualifier_ui | Q000379 |
| mesh[5].descriptor_ui | D062028 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | methods |
| mesh[5].descriptor_name | Bioprinting |
| mesh[6].qualifier_ui | Q000379 |
| mesh[6].descriptor_ui | D000076722 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | methods |
| mesh[6].descriptor_name | Drug Development |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D066330 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Printing, Three-Dimensional |
| mesh[9].qualifier_ui | Q000379 |
| mesh[9].descriptor_ui | D023822 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | methods |
| mesh[9].descriptor_name | Tissue Engineering |
| type | editorial |
| title | Can 4D bioprinting revolutionize drug development? |
| biblio.issue | 10 |
| biblio.volume | 14 |
| biblio.last_page | 956 |
| biblio.first_page | 953 |
| topics[0].id | https://openalex.org/T11190 |
| topics[0].field.id | https://openalex.org/fields/22 |
| topics[0].field.display_name | Engineering |
| topics[0].score | 0.9995999932289124 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2204 |
| topics[0].subfield.display_name | Biomedical Engineering |
| topics[0].display_name | 3D Printing in Biomedical Research |
| topics[1].id | https://openalex.org/T10783 |
| topics[1].field.id | https://openalex.org/fields/22 |
| topics[1].field.display_name | Engineering |
| topics[1].score | 0.9968000054359436 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2203 |
| topics[1].subfield.display_name | Automotive Engineering |
| topics[1].display_name | Additive Manufacturing and 3D Printing Technologies |
| topics[2].id | https://openalex.org/T12784 |
| topics[2].field.id | https://openalex.org/fields/22 |
| topics[2].field.display_name | Engineering |
| topics[2].score | 0.9868999719619751 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2210 |
| topics[2].subfield.display_name | Mechanical Engineering |
| topics[2].display_name | Modular Robots and Swarm Intelligence |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C66782513 |
| concepts[0].level | 2 |
| concepts[0].score | 0.716651439666748 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q864601 |
| concepts[0].display_name | Biomedicine |
| concepts[1].id | https://openalex.org/C2779718196 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6894562840461731 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q17018741 |
| concepts[1].display_name | 3D bioprinting |
| concepts[2].id | https://openalex.org/C64903051 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5422734618186951 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2198549 |
| concepts[2].display_name | Drug development |
| concepts[3].id | https://openalex.org/C171056886 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5255540609359741 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q193119 |
| concepts[3].display_name | Regeneration (biology) |
| concepts[4].id | https://openalex.org/C2780035454 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4347115755081177 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[4].display_name | Drug |
| concepts[5].id | https://openalex.org/C171250308 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4281374216079712 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11468 |
| concepts[5].display_name | Nanotechnology |
| concepts[6].id | https://openalex.org/C71924100 |
| concepts[6].level | 0 |
| concepts[6].score | 0.36173680424690247 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[6].display_name | Medicine |
| concepts[7].id | https://openalex.org/C41008148 |
| concepts[7].level | 0 |
| concepts[7].score | 0.3345745801925659 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[7].display_name | Computer science |
| concepts[8].id | https://openalex.org/C60644358 |
| concepts[8].level | 1 |
| concepts[8].score | 0.21943747997283936 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q128570 |
| concepts[8].display_name | Bioinformatics |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.20262295007705688 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C98274493 |
| concepts[10].level | 1 |
| concepts[10].score | 0.17098358273506165 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[10].display_name | Pharmacology |
| concepts[11].id | https://openalex.org/C136229726 |
| concepts[11].level | 1 |
| concepts[11].score | 0.16101092100143433 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q327092 |
| concepts[11].display_name | Biomedical engineering |
| concepts[12].id | https://openalex.org/C49892992 |
| concepts[12].level | 2 |
| concepts[12].score | 0.1564311981201172 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q1540285 |
| concepts[12].display_name | Tissue engineering |
| concepts[13].id | https://openalex.org/C192562407 |
| concepts[13].level | 0 |
| concepts[13].score | 0.13174745440483093 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[13].display_name | Materials science |
| concepts[14].id | https://openalex.org/C95444343 |
| concepts[14].level | 1 |
| concepts[14].score | 0.06184092164039612 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[14].display_name | Cell biology |
| keywords[0].id | https://openalex.org/keywords/biomedicine |
| keywords[0].score | 0.716651439666748 |
| keywords[0].display_name | Biomedicine |
| keywords[1].id | https://openalex.org/keywords/3d-bioprinting |
| keywords[1].score | 0.6894562840461731 |
| keywords[1].display_name | 3D bioprinting |
| keywords[2].id | https://openalex.org/keywords/drug-development |
| keywords[2].score | 0.5422734618186951 |
| keywords[2].display_name | Drug development |
| keywords[3].id | https://openalex.org/keywords/regeneration |
| keywords[3].score | 0.5255540609359741 |
| keywords[3].display_name | Regeneration (biology) |
| keywords[4].id | https://openalex.org/keywords/drug |
| keywords[4].score | 0.4347115755081177 |
| keywords[4].display_name | Drug |
| keywords[5].id | https://openalex.org/keywords/nanotechnology |
| keywords[5].score | 0.4281374216079712 |
| keywords[5].display_name | Nanotechnology |
| keywords[6].id | https://openalex.org/keywords/medicine |
| keywords[6].score | 0.36173680424690247 |
| keywords[6].display_name | Medicine |
| keywords[7].id | https://openalex.org/keywords/computer-science |
| keywords[7].score | 0.3345745801925659 |
| keywords[7].display_name | Computer science |
| keywords[8].id | https://openalex.org/keywords/bioinformatics |
| keywords[8].score | 0.21943747997283936 |
| keywords[8].display_name | Bioinformatics |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.20262295007705688 |
| keywords[9].display_name | Biology |
| keywords[10].id | https://openalex.org/keywords/pharmacology |
| keywords[10].score | 0.17098358273506165 |
| keywords[10].display_name | Pharmacology |
| keywords[11].id | https://openalex.org/keywords/biomedical-engineering |
| keywords[11].score | 0.16101092100143433 |
| keywords[11].display_name | Biomedical engineering |
| keywords[12].id | https://openalex.org/keywords/tissue-engineering |
| keywords[12].score | 0.1564311981201172 |
| keywords[12].display_name | Tissue engineering |
| keywords[13].id | https://openalex.org/keywords/materials-science |
| keywords[13].score | 0.13174745440483093 |
| keywords[13].display_name | Materials science |
| keywords[14].id | https://openalex.org/keywords/cell-biology |
| keywords[14].score | 0.06184092164039612 |
| keywords[14].display_name | Cell biology |
| language | en |
| locations[0].id | doi:10.1080/17460441.2019.1636781 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S142541038 |
| locations[0].source.issn | 1746-0441, 1746-045X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1746-0441 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Expert Opinion on Drug Discovery |
| locations[0].source.host_organization | https://openalex.org/P4310320547 |
| locations[0].source.host_organization_name | Taylor & Francis |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320547 |
| locations[0].license | |
| locations[0].pdf_url | https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1636781?needAccess=true |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Expert Opinion on Drug Discovery |
| locations[0].landing_page_url | https://doi.org/10.1080/17460441.2019.1636781 |
| locations[1].id | pmid:31282226 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Expert opinion on drug discovery |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/31282226 |
| locations[2].id | pmh:oai:repository.ubn.ru.nl:2066/215393 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401067 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Radboud Repository (Radboud University) |
| locations[2].source.host_organization | https://openalex.org/I145872427 |
| locations[2].source.host_organization_name | Radboud University Nijmegen |
| locations[2].source.host_organization_lineage | https://openalex.org/I145872427 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Article / Letter to editor |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Expert Opinion on Drug Discovery, 14, 10, pp. 953-956 |
| locations[2].landing_page_url | http://hdl.handle.net/2066/215393 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5034836692 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1871-2754 |
| authorships[0].author.display_name | Izeia Lukin |
| authorships[0].countries | ES |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210105141 |
| authorships[0].affiliations[0].raw_affiliation_string | Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I169108374 |
| authorships[0].affiliations[1].raw_affiliation_string | NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain |
| authorships[0].institutions[0].id | https://openalex.org/I4210105141 |
| authorships[0].institutions[0].ror | https://ror.org/01gm5f004 |
| authorships[0].institutions[0].type | other |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210105141 |
| authorships[0].institutions[0].country_code | ES |
| authorships[0].institutions[0].display_name | Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine |
| authorships[0].institutions[1].id | https://openalex.org/I169108374 |
| authorships[0].institutions[1].ror | https://ror.org/000xsnr85 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I169108374 |
| authorships[0].institutions[1].country_code | ES |
| authorships[0].institutions[1].display_name | University of the Basque Country |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Izeia Lukin |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain, NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain |
| authorships[1].author.id | https://openalex.org/A5032193664 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Saioa Musquiz |
| authorships[1].countries | ES |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I169108374 |
| authorships[1].affiliations[0].raw_affiliation_string | NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I4210105141 |
| authorships[1].affiliations[1].raw_affiliation_string | Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain |
| authorships[1].institutions[0].id | https://openalex.org/I4210105141 |
| authorships[1].institutions[0].ror | https://ror.org/01gm5f004 |
| authorships[1].institutions[0].type | other |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210105141 |
| authorships[1].institutions[0].country_code | ES |
| authorships[1].institutions[0].display_name | Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine |
| authorships[1].institutions[1].id | https://openalex.org/I169108374 |
| authorships[1].institutions[1].ror | https://ror.org/000xsnr85 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I169108374 |
| authorships[1].institutions[1].country_code | ES |
| authorships[1].institutions[1].display_name | University of the Basque Country |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Saioa Musquiz |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain, NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain |
| authorships[2].author.id | https://openalex.org/A5037384262 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Itsasne Erezuma |
| authorships[2].countries | ES |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210105141 |
| authorships[2].affiliations[0].raw_affiliation_string | Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I169108374 |
| authorships[2].affiliations[1].raw_affiliation_string | NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain |
| authorships[2].institutions[0].id | https://openalex.org/I4210105141 |
| authorships[2].institutions[0].ror | https://ror.org/01gm5f004 |
| authorships[2].institutions[0].type | other |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210105141 |
| authorships[2].institutions[0].country_code | ES |
| authorships[2].institutions[0].display_name | Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine |
| authorships[2].institutions[1].id | https://openalex.org/I169108374 |
| authorships[2].institutions[1].ror | https://ror.org/000xsnr85 |
| authorships[2].institutions[1].type | education |
| authorships[2].institutions[1].lineage | https://openalex.org/I169108374 |
| authorships[2].institutions[1].country_code | ES |
| authorships[2].institutions[1].display_name | University of the Basque Country |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Itsasne Erezuma |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain, NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain |
| authorships[3].author.id | https://openalex.org/A5113658738 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Taleb H. Al‐Tel |
| authorships[3].countries | AE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I29891158 |
| authorships[3].affiliations[0].raw_affiliation_string | Sharjah Institute for Medical Research and College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates |
| authorships[3].institutions[0].id | https://openalex.org/I29891158 |
| authorships[3].institutions[0].ror | https://ror.org/00engpz63 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I29891158 |
| authorships[3].institutions[0].country_code | AE |
| authorships[3].institutions[0].display_name | University of Sharjah |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Taleb H. Al-Tel |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Sharjah Institute for Medical Research and College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates |
| authorships[4].author.id | https://openalex.org/A5065598766 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-4561-8846 |
| authorships[4].author.display_name | Nasim Golafshan |
| authorships[4].countries | NL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I193662353, https://openalex.org/I3018483916 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Orthopedics, University Medical Center, Utrecht University, Utrecht, The Netherlands |
| authorships[4].institutions[0].id | https://openalex.org/I3018483916 |
| authorships[4].institutions[0].ror | https://ror.org/0575yy874 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I3018483916 |
| authorships[4].institutions[0].country_code | NL |
| authorships[4].institutions[0].display_name | University Medical Center Utrecht |
| authorships[4].institutions[1].id | https://openalex.org/I193662353 |
| authorships[4].institutions[1].ror | https://ror.org/04pp8hn57 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I193662353 |
| authorships[4].institutions[1].country_code | NL |
| authorships[4].institutions[1].display_name | Utrecht University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Nasim Golafshan |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Orthopedics, University Medical Center, Utrecht University, Utrecht, The Netherlands |
| authorships[5].author.id | https://openalex.org/A5082661377 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-6326-0836 |
| authorships[5].author.display_name | Alireza Dolatshahi‐Pirouz |
| authorships[5].countries | DK, NL |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I145872427, https://openalex.org/I2802934949 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Regenerative Biomaterials, Radboud University Medical Center, Nijmegen, The Netherlands |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I96673099 |
| authorships[5].affiliations[1].raw_affiliation_string | Department of Health Technology, Center for Intestinal Absorption and Transport of Biopharmaceuticals, Technical University of Denmark, Denmark |
| authorships[5].institutions[0].id | https://openalex.org/I96673099 |
| authorships[5].institutions[0].ror | https://ror.org/04qtj9h94 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I96673099 |
| authorships[5].institutions[0].country_code | DK |
| authorships[5].institutions[0].display_name | Technical University of Denmark |
| authorships[5].institutions[1].id | https://openalex.org/I2802934949 |
| authorships[5].institutions[1].ror | https://ror.org/05wg1m734 |
| authorships[5].institutions[1].type | healthcare |
| authorships[5].institutions[1].lineage | https://openalex.org/I2802934949 |
| authorships[5].institutions[1].country_code | NL |
| authorships[5].institutions[1].display_name | Radboud University Medical Center |
| authorships[5].institutions[2].id | https://openalex.org/I145872427 |
| authorships[5].institutions[2].ror | https://ror.org/016xsfp80 |
| authorships[5].institutions[2].type | education |
| authorships[5].institutions[2].lineage | https://openalex.org/I145872427 |
| authorships[5].institutions[2].country_code | NL |
| authorships[5].institutions[2].display_name | Radboud University Nijmegen |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Alireza Dolatshahi-Pirouz |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Health Technology, Center for Intestinal Absorption and Transport of Biopharmaceuticals, Technical University of Denmark, Denmark, Department of Regenerative Biomaterials, Radboud University Medical Center, Nijmegen, The Netherlands |
| authorships[6].author.id | https://openalex.org/A5031536814 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0773-300X |
| authorships[6].author.display_name | Gorka Orive |
| authorships[6].countries | ES, SG |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210105825 |
| authorships[6].affiliations[0].raw_affiliation_string | University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Spain |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I169108374 |
| authorships[6].affiliations[1].raw_affiliation_string | NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain |
| authorships[6].affiliations[2].institution_ids | https://openalex.org/I4210105141 |
| authorships[6].affiliations[2].raw_affiliation_string | Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain |
| authorships[6].affiliations[3].institution_ids | https://openalex.org/I4210116917 |
| authorships[6].affiliations[3].raw_affiliation_string | Singapore Eye Research Institute, The Academia, Singapore |
| authorships[6].institutions[0].id | https://openalex.org/I4210105825 |
| authorships[6].institutions[0].ror | https://ror.org/01me5n293 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210105825 |
| authorships[6].institutions[0].country_code | ES |
| authorships[6].institutions[0].display_name | BTI Biotechnology Institute |
| authorships[6].institutions[1].id | https://openalex.org/I4210105141 |
| authorships[6].institutions[1].ror | https://ror.org/01gm5f004 |
| authorships[6].institutions[1].type | other |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210105141 |
| authorships[6].institutions[1].country_code | ES |
| authorships[6].institutions[1].display_name | Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine |
| authorships[6].institutions[2].id | https://openalex.org/I169108374 |
| authorships[6].institutions[2].ror | https://ror.org/000xsnr85 |
| authorships[6].institutions[2].type | education |
| authorships[6].institutions[2].lineage | https://openalex.org/I169108374 |
| authorships[6].institutions[2].country_code | ES |
| authorships[6].institutions[2].display_name | University of the Basque Country |
| authorships[6].institutions[3].id | https://openalex.org/I4210116917 |
| authorships[6].institutions[3].ror | https://ror.org/02crz6e12 |
| authorships[6].institutions[3].type | facility |
| authorships[6].institutions[3].lineage | https://openalex.org/I4210116917 |
| authorships[6].institutions[3].country_code | SG |
| authorships[6].institutions[3].display_name | Singapore Eye Research Institute |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Gorka Orive |
| authorships[6].is_corresponding | True |
| authorships[6].raw_affiliation_strings | Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Vitoria-Gasteiz, Spain, NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain, Singapore Eye Research Institute, The Academia, Singapore, University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua), Vitoria, Spain |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1636781?needAccess=true |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Can 4D bioprinting revolutionize drug development? |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11190 |
| primary_topic.field.id | https://openalex.org/fields/22 |
| primary_topic.field.display_name | Engineering |
| primary_topic.score | 0.9995999932289124 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2204 |
| primary_topic.subfield.display_name | Biomedical Engineering |
| primary_topic.display_name | 3D Printing in Biomedical Research |
| related_works | https://openalex.org/W2017899917, https://openalex.org/W2080571363, https://openalex.org/W2481322495, https://openalex.org/W2898682754, https://openalex.org/W2889841093, https://openalex.org/W2151082141, https://openalex.org/W2365236913, https://openalex.org/W3194374240, https://openalex.org/W2993861175, https://openalex.org/W1585256759 |
| cited_by_count | 35 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 7 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 4 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 10 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 7 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 3 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1080/17460441.2019.1636781 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S142541038 |
| best_oa_location.source.issn | 1746-0441, 1746-045X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1746-0441 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Expert Opinion on Drug Discovery |
| best_oa_location.source.host_organization | https://openalex.org/P4310320547 |
| best_oa_location.source.host_organization_name | Taylor & Francis |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320547 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1636781?needAccess=true |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Expert Opinion on Drug Discovery |
| best_oa_location.landing_page_url | https://doi.org/10.1080/17460441.2019.1636781 |
| primary_location.id | doi:10.1080/17460441.2019.1636781 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S142541038 |
| primary_location.source.issn | 1746-0441, 1746-045X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1746-0441 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Expert Opinion on Drug Discovery |
| primary_location.source.host_organization | https://openalex.org/P4310320547 |
| primary_location.source.host_organization_name | Taylor & Francis |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320547 |
| primary_location.license | |
| primary_location.pdf_url | https://www.tandfonline.com/doi/pdf/10.1080/17460441.2019.1636781?needAccess=true |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Expert Opinion on Drug Discovery |
| primary_location.landing_page_url | https://doi.org/10.1080/17460441.2019.1636781 |
| publication_date | 2019-07-08 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2341972548, https://openalex.org/W2006877588, https://openalex.org/W1621997758, https://openalex.org/W2176956992, https://openalex.org/W2506754678, https://openalex.org/W2339308292, https://openalex.org/W2179546763, https://openalex.org/W2823847891, https://openalex.org/W2757953015, https://openalex.org/W2226257595, https://openalex.org/W2892300066, https://openalex.org/W2266720690, https://openalex.org/W2895024215, https://openalex.org/W2063333995, https://openalex.org/W2944203705, https://openalex.org/W2271396956, https://openalex.org/W2055549058, https://openalex.org/W1986326540, https://openalex.org/W2789089223, https://openalex.org/W2065678169, https://openalex.org/W2281389999, https://openalex.org/W2560786562, https://openalex.org/W1990612778, https://openalex.org/W2945345228, https://openalex.org/W2557679828, https://openalex.org/W2317462811, https://openalex.org/W4243006789, https://openalex.org/W2809894170, https://openalex.org/W2757499578 |
| referenced_works_count | 29 |
| abstract_inverted_index.) | 7 |
| abstract_inverted_index.\n | 0 |
| abstract_inverted_index.:\n | 3 |
| abstract_inverted_index.(Closed | 8 |
| abstract_inverted_index.version | 6 |
| abstract_inverted_index.Contains | 1 |
| abstract_inverted_index.fulltext | 2 |
| abstract_inverted_index.access)\n | 9 |
| abstract_inverted_index.215393.pdf | 4 |
| abstract_inverted_index.(Publisher’s | 5 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 96 |
| corresponding_author_ids | https://openalex.org/A5031536814 |
| countries_distinct_count | 5 |
| institutions_distinct_count | 7 |
| corresponding_institution_ids | https://openalex.org/I169108374, https://openalex.org/I4210105141, https://openalex.org/I4210105825, https://openalex.org/I4210116917 |
| citation_normalized_percentile.value | 0.85546333 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |